Isabelle Martins Selected Research

Neoplasms (Cancer)

1/2024	Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer.
1/2024	Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics.
1/2024	Orthotopic Model of Hepatocellular Carcinoma in Mice.
10/2023	Protein regulator of cytokinesis 1: a potential oncogenic driver.
1/2023	New hormone receptor-positive breast cancer mouse cell line mimicking the immune microenvironment of anti-PD-1 resistant mammary carcinoma.
1/2022	Cancer cell-autonomous overactivation of PARP1 compromises immunosurveillance in non-small cell lung cancer.
10/2021	Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinoma.
1/2021	A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency.
1/2021	Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index.
1/2021	Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Martins Research Topics

Disease

48	Neoplasms (Cancer) 01/2024 - 08/2009
10	Obesity 01/2023 - 10/2019
5	Necrosis 01/2017 - 11/2009
4	Starvation 01/2021 - 10/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 07/2012
3	Carcinoma (Carcinomatosis) 01/2023 - 12/2012
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2012
3	Lung Neoplasms (Lung Cancer) 01/2022 - 08/2012
3	Weight Gain 01/2022 - 10/2019
3	Tetraploidy 11/2021 - 01/2013
3	Melanoma (Melanoma, Malignant) 06/2012 - 03/2007
2	Liver Neoplasms (Liver Cancer) 01/2024 - 01/2024
2	Non-alcoholic Fatty Liver Disease 01/2024 - 10/2022
2	Carcinogenesis 01/2024 - 01/2013
2	Body Weight (Weight, Body) 01/2024 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 10/2022
2	Breast Neoplasms (Breast Cancer) 01/2023 - 05/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2023
2	Myocardial Infarction 01/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2023 - 10/2022
2	Infections 01/2023 - 08/2011
2	Stroke (Strokes) 01/2023 - 01/2023
2	Hypoxia (Hypoxemia) 01/2021 - 08/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2013
1	Diabetes Mellitus 01/2024
1	Type 2 Diabetes Mellitus (MODY) 01/2024
1	Wounds and Injuries (Trauma) 01/2024
1	Alcoholic Fatty Liver 01/2024
1	Cardiotoxicity 01/2023
1	Ischemia 10/2022
1	Infarction (Infarctions) 10/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022
1	Reperfusion Injury 10/2022
1	Amyloidosis 03/2022

Drug/Important Bio-Agent (IBA)

13	5-methoxy-methylindoleacetic acid (DBI)IBA 01/2023 - 10/2019
10	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2010
10	Adenosine Triphosphate (ATP)IBA 08/2013 - 11/2009
8	AnthracyclinesIBA 01/2023 - 02/2010
6	Diazepam Binding InhibitorIBA 01/2023 - 10/2019
6	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2012
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018 - 02/2010
5	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 06/2012
5	AntigensIBA 01/2020 - 10/2010
5	CalreticulinIBA 01/2020 - 12/2009
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2023
4	LigandsIBA 01/2021 - 10/2010
4	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 09/2012
4	VaccinesIBA 10/2014 - 03/2012
3	CarcinogensIBA 01/2024 - 09/2012
3	Acyl Coenzyme A (Acyl CoA)IBA 01/2023 - 12/2020
3	Carrier Proteins (Binding Protein)IBA 01/2023 - 12/2020
3	EnzymesIBA 01/2023 - 12/2011
3	Phosphotransferases (Kinase)IBA 01/2021 - 08/2009
3	Neoplasm Antigens (Tumor Antigens)IBA 08/2017 - 03/2011
3	HMGB1 Protein (HMG1)IBA 08/2013 - 03/2012
3	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 08/2011
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2024 - 10/2022
2	Formaldehyde (Formol)FDA Link 01/2024 - 08/2012
2	ParaffinIBA 01/2024 - 08/2012
2	LipidsIBA 01/2024 - 01/2021
2	Monoclonal AntibodiesIBA 01/2023 - 10/2022
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2021
2	gamma-Aminobutyric Acid (GABA)IBA 01/2023 - 01/2022
2	Green Fluorescent ProteinsIBA 01/2021 - 01/2013
2	Pattern Recognition ReceptorsIBA 01/2021 - 05/2012
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 01/2021
2	HLA-DR Antigens (HLA-DR)IBA 08/2013 - 08/2009
2	Digoxin (Digitek)FDA LinkGeneric 12/2012 - 07/2012
2	Cytotoxins (Cytolysins)IBA 08/2012 - 10/2010
2	Mitogen-Activated Protein KinasesIBA 08/2009 - 03/2007
1	SugarsIBA 01/2024
1	(L)-Isomer Glucose (L-Glucose)IBA 01/2024
1	Glycerophospholipids (Phosphoglycerides)IBA 01/2024
1	Streptozocin (Streptozotocin)FDA Link 01/2024
1	FructoseIBA 01/2024
1	CholesterolIBA 01/2024
1	IntegrinsIBA 10/2023
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 10/2023
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2023
1	Hormones (Hormone)IBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2022
1	Choline (Choline Chloride)IBA 10/2022
1	Concanavalin AIBA 10/2022
1	Methionine (L-Methionine)FDA Link 10/2022
1	Protein AggregatesIBA 03/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 03/2022
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	Poly (ADP-Ribose) Polymerase-1IBA 01/2022

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 01/2023 - 11/2009
12	Therapeutics 01/2024 - 02/2010
5	Radiotherapy 01/2018 - 01/2017
2	Intraperitoneal Injections 01/2024 - 01/2024
2	Immunotherapy 01/2023 - 01/2021
1	Sutures (Suture) 01/2024
1	Operative Surgical Procedures 01/2024
1	Laparotomy 01/2024
1	Postoperative Care 01/2024
1	Ligation 10/2022